Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hydralazine and lupus nephritis.

B U Ihle, J A Whitworth, J P Dowling

    Clinical Nephrology
    |November 1, 1984
    PubMed
    Summary

    Hydralazine can cause lupus-like illness, including immune complex glomerulonephritis, particularly in slow acetylators. Treatment involves stopping hydralazine and using immunosuppressants for recovery.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Design of microresonators to minimize thermal noise below the standard quantum limit.

    The Review of scientific instruments·2020
    Same author

    Toward Scalable Boson Sampling with Photon Loss.

    Physical review letters·2018
    Same author

    Women and global health: a personal view.

    Global health, epidemiology and genomics·2018
    Same author

    An unusual onset of agminated Spitz naevi in an adult patient.

    Clinical and experimental dermatology·2017
    Same author

    The role of sustained release isosorbide mononitrate on corticosteroid-induced hypertension in healthy human subjects.

    Journal of human hypertension·2015
    Same author

    Decreased threshold for the nitric oxide donor glyceryl trinitrate in cortisol-induced hypertension in humans.

    Clinical and experimental pharmacology & physiology·2007

    Area of Science:

    • Nephrology
    • Rheumatology
    • Clinical Pharmacology

    Background:

    • Hydralazine is an antihypertensive drug.
    • Systemic lupus erythematosus (SLE) is an autoimmune disease.
    • Renal involvement in drug-induced SLE is typically uncommon.

    Observation:

    • Six women with hypertension developed immune complex glomerulonephritis after taking hydralazine.
    • Patients exhibited anemia, hypocomplementemia, positive antinuclear antibody, and anti-double-stranded DNA antibodies.
    • All patients were slow acetylators, and four had the HLA-DR 4 genotype.

    Findings:

    • Hydralazine use was linked to lupus glomerulonephritis in these patients.
    • Renal function declined in all affected individuals.
    • Genetic factors (slow acetylator phenotype, HLA-DR 4) may predispose individuals to this reaction.

    Implications:

    • Hydralazine should be used cautiously in patients with potential risk factors.
    • Early recognition and cessation of hydralazine are crucial for managing hydralazine-induced lupus nephritis.
    • Immunosuppressive therapy alongside hydralazine withdrawal can lead to disease improvement.

    Related Experiment Videos